An interventional study of Carbon dioxide and Bupivacaine in Laparoscopic Surgery, sponsored by Cedars-Sinai Medical Center. Recruiting at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-05-10.
Sponsored by Cedars-Sinai Medical Center · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 17 studies in Pneumoperitoneum with a site in United States — 4 open to participants now, 4 under way, none of them phase 3. Pneumoperitoneum · United States.
Among the 17 studies in Pneumoperitoneum with a site in United States, this one has the largest planned enrollment of the 14 interventional ones that give a count, is the only one that started in 2024, is one of 14 with no phase, and was the 14th registered.
133 studies on the registry are indexed under Pneumoperitoneum; 28 are open to participants now.
Browse Pneumoperitoneum studies →4 of the 17 studies in Pneumoperitoneum with a site in United States are open now. Recruiting first, the newest first:
Weill Medical College of Cornell University · Sites in United States
Ages 18+
Henry Ford Health System · Sites in United States
Ages 18–65 · Women only · Healthy volunteers
Riverside University Health System Medical Center · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 13 Pneumoperitoneum studies recruiting now, 8 (62%) set no upper age limit and 3 (23%) stop at 75 or younger; 1 takes children under 18; 1 takes healthy volunteers.
This study: 18 Years and older · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
17 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 1 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 294 is above the median of 76 across 77 interventional studies indexed under Pneumoperitoneum.
Median enrollment 70 across the 14 interventional studies, 70 across the 2 observational. Of the 9 that completed or were terminated, 3 (33%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 17 have an industry lead sponsor. The 10 most frequent:
Cedars-Sinai Medical Center is the lead sponsor of 457 studies on the registry; 108 are open to participants now.
Of its 65 completed or terminated interventional studies of FDA-regulated products, 49 (75%) have results posted.
Cedars-Sinai Medical Center has 1 study filed under Pneumoperitoneum — fewer than ten, so there is no comparison to draw.
2 of the studies in Pneumoperitoneum with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07710352Weill Medical College of Cornell UniversityLow Gas Pressure vs Standard Gas Pressure in Robotic Surgery | 2027-01 |
| NCT06338865Cedars-Sinai Medical CenterShort Title: Standard vs. Lower Pressure Pneumoperitoneum | 2027-04 |
Add all 2 to your calendar (.ics) → With an account.
Among the 17 studies in Pneumoperitoneum with a site in United States, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This study aims to investigate the effect of varying insufflation pressures on post-operative pain and adequacy of surgical field visualization among patients undergoing laparoscopic surgery with a minimally invasive gynecologic surgeon.
This will be a single-center, single-blinded randomized controlled trial evaluating the impact of lower pressure pneumoperitoneum on post-operative pain and surgical field visualization among patients undergoing laparoscopic gynecologic surgery. The investigators hypothesize that lower insufflation pressures will decrease post-operative pain in the immediate post-operative period without compromising surgical field visualization. The study will include 3 groups corresponding to varying insufflation pressures: 15mmHg (standard), 12mmHg and 10mmHg. Participants will be 1:1:1 allocated to the 15mmHg, 12mmHg or 10mmHg groups (parallel design) by block randomization.
Given inherent differences in how pneumoperitoneum is maintained during conventional versus robotic-assisted laparoscopic surgery, the investigators will be enrolling patients in two separate arms depending on their planned procedure:
The methodology for the two arms will be otherwise identical.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Standard Pressure, Conventional Laparoscopic Arm
Other: Carbon dioxide · Drug: Bupivacaine · Drug: Oxycodone
Lower Pressure, Conventional Laparoscopic Arm
Other: Carbon dioxide · Drug: Bupivacaine · Drug: Oxycodone
Lowest Pressure, Conventional Laparoscopic Arm
Other: Carbon dioxide · Drug: Bupivacaine · Drug: Oxycodone
Standard Pressure, Robotic-Assisted Laparoscopic Arm
Other: Carbon dioxide · Drug: Bupivacaine · Drug: Oxycodone
Lower Pressure, Robotic-Assisted Laparoscopic Arm
Other: Carbon dioxide · Drug: Bupivacaine · Drug: Oxycodone
Lowest Pressure, Robotic-Assisted Laparoscopic Arm
Other: Carbon dioxide · Drug: Bupivacaine · Drug: Oxycodone
Gas used for insufflation pressure
Local subcutaneous infiltration of all port sites with 0.25% bupivacaine will be performed prior to each incision. Remaining local anesthetic will be administered into the incision sites prior to the conclusion of the case (30cc total).
All patients will be prescribed a total of 10 pills of oxycodone 5mg, which is the standard amount that our practice prescribes for patients after laparoscopic surgery.
Maximum documented pain score in post-anesthesia care unit (PACU) (numerical rating scale, 0-10)
The numerical rating scale is a pain screening tool that is routinely used to assess pain severity in the postoperative setting using a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable."
Time frame: Postoperatively, before discharge from PACU (postoperative day 0)
First reported pain score in PACU (numerical rating scale, 0-10)
The numerical rating scale is a pain screening tool that is routinely used to assess pain severity in the postoperative setting using a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable."
Time frame: Immediately upon arrival to PACU (postoperative day 0)
Last reported pain score in PACU prior to discharge (numerical rating scale, 0-10)
The numerical rating scale is a pain screening tool that is routinely used to assess pain severity in the postoperative setting using a 0-10 scale, with zero meaning "no pain" and 10 meaning "the worst pain imaginable."
Time frame: Immediately prior to discharge from PACU (postoperative day 0)
Inpatient morphine milligram equivalents
Daily total of opioid medications administered on the day of surgery
Time frame: Day of surgery (postoperative day 0)
Total number of 5mg oxycodone pills taken in the 2 weeks following discharge
Time frame: Assessed at postoperative day 14
Need for insufflation pressure increase intra-operatively due to inadequate visualization
Time frame: Intraoperative
Operative time
Time frame: Intraoperative
Estimated blood loss
Time frame: Intraoperative
Intraoperative complications
Time frame: Intraoperative
Conversion to laparotomy
Time frame: Intraoperative
Postoperative length of stay
From arrival to PACU to discharge home
Time frame: Postoperatively, before discharge from PACU (postoperative day 0)
Surgeon-reported adequacy of assigned insufflation pressure
Surgeons will rate their agreement with the following statement on a 5-point Likert scale (from strongly disagree to strongly agree): "The assigned insufflation pressure was adequate for this procedure"
Time frame: Immediately following surgery
Need for adjustment of insufflation pressure
In a post-op questionnaire, surgeons will indicate whether the insufflation pressure was adjusted at any point during the procedure (yes/no).
Time frame: Intraoperative
Plan to share: No
No publications or documents are linked to this record.
Started May 2024 (actual). Primary completion is estimated for Apr 2027, 35 months after the start.
Of 40 non-industry interventional studies with no phase under Pneumoperitoneum, half reached primary completion within 8 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 14. This study's planned 35 months is above that.
Counting every sponsor, half of 40 studies reached it within 8 months; a quarter within 4 and three quarters within 14.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Bupivacaine · Oxycodone